Trader consensus implies a 78% probability that the CDC will not issue a Level 4 "Avoid All Travel" notice for any disease by December 31, 2026, reflecting current CDC surveillance data showing no active Level 4 or even Level 3 travel health notices amid contained outbreaks. Sporadic H5N1 avian influenza cases—71 in the US since 2024, including a recent cat-to-human transmission confirmed May 13—lack evidence of sustained human-to-human transmission, keeping it below notice thresholds. Global polio circulation prompted a Level 2 update in March 2026 for 30+ countries, while clade II mpox remains Level 2 in Ghana and Liberia, and rising measles cases sustain only a Level 1 global alert urging MMR vaccination. Absent explosive epidemics, traders anticipate ongoing monitoring through the 2026 respiratory season without escalation to Level 4 criteria.
Polymarket ডেটা রেফারেন্স করে পরীক্ষামূলক AI-জেনারেটেড সারাংশ। এটি ট্রেডিং পরামর্শ নয় এবং এই মার্কেট কীভাবে রেজলভ হয় তাতে কোনো ভূমিকা রাখে না। · আপডেটেডCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$71,394 Vol.
$71,394 Vol.
Dec 31, 2026
$71,394 Vol.
$71,394 Vol.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus implies a 78% probability that the CDC will not issue a Level 4 "Avoid All Travel" notice for any disease by December 31, 2026, reflecting current CDC surveillance data showing no active Level 4 or even Level 3 travel health notices amid contained outbreaks. Sporadic H5N1 avian influenza cases—71 in the US since 2024, including a recent cat-to-human transmission confirmed May 13—lack evidence of sustained human-to-human transmission, keeping it below notice thresholds. Global polio circulation prompted a Level 2 update in March 2026 for 30+ countries, while clade II mpox remains Level 2 in Ghana and Liberia, and rising measles cases sustain only a Level 1 global alert urging MMR vaccination. Absent explosive epidemics, traders anticipate ongoing monitoring through the 2026 respiratory season without escalation to Level 4 criteria.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
মার্কেট ওপেন হয়েছে: Jan 19, 2026, 3:15 PM ET
ভলিউম
$71,394শেষ তারিখ
Dec 31, 2026মার্কেট ওপেন হয়েছে
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus implies a 78% probability that the CDC will not issue a Level 4 "Avoid All Travel" notice for any disease by December 31, 2026, reflecting current CDC surveillance data showing no active Level 4 or even Level 3 travel health notices amid contained outbreaks. Sporadic H5N1 avian influenza cases—71 in the US since 2024, including a recent cat-to-human transmission confirmed May 13—lack evidence of sustained human-to-human transmission, keeping it below notice thresholds. Global polio circulation prompted a Level 2 update in March 2026 for 30+ countries, while clade II mpox remains Level 2 in Ghana and Liberia, and rising measles cases sustain only a Level 1 global alert urging MMR vaccination. Absent explosive epidemics, traders anticipate ongoing monitoring through the 2026 respiratory season without escalation to Level 4 criteria.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
ভলিউম
$71,394শেষ তারিখ
Dec 31, 2026মার্কেট ওপেন হয়েছে
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus implies a 78% probability that the CDC will not issue a Level 4 "Avoid All Travel" notice for any disease by December 31, 2026, reflecting current CDC surveillance data showing no active Level 4 or even Level 3 travel health notices amid contained outbreaks. Sporadic H5N1 avian influenza cases—71 in the US since 2024, including a recent cat-to-human transmission confirmed May 13—lack evidence of sustained human-to-human transmission, keeping it below notice thresholds. Global polio circulation prompted a Level 2 update in March 2026 for 30+ countries, while clade II mpox remains Level 2 in Ghana and Liberia, and rising measles cases sustain only a Level 1 global alert urging MMR vaccination. Absent explosive epidemics, traders anticipate ongoing monitoring through the 2026 respiratory season without escalation to Level 4 criteria.
Polymarket ডেটা রেফারেন্স করে পরীক্ষামূলক AI-জেনারেটেড সারাংশ। এটি ট্রেডিং পরামর্শ নয় এবং এই মার্কেট কীভাবে রেজলভ হয় তাতে কোনো ভূমিকা রাখে না। · আপডেটেড
বাহ্যিক লিংক থেকে সাবধান।
বাহ্যিক লিংক থেকে সাবধান।
সচরাচর জিজ্ঞাসা